- Rating
- 3
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
The paper proposes QPD, a contrastive training loss that supervises the temporal order in which per-residue backbone rotations compose in generated protein MD trajectories. Positives follow the ground-truth increment order; negatives are built with the Hurwitz move, which preserves the net endpoint but changes intermediate order. QPD adds no learnable parameters and is evaluated on ATLAS ensembles, MDGen tetrapeptides, CATH2-OOD20 kinetics, ADK transition paths and DD-13M ligand dissociation, with an order-gap control based on frame permutation.
Critical strengths
-
The idea is sensible and efficient. Most current work targets conformational ensemble generation, where performance is already strong; dynamic/trajectory models are fewer, and directly learning protein dynamics is hard. QPD addresses this gap with a lightweight, zero-parameter loss that can be attached to coordinate-predicting generators, including ensemble generators, and it is motivated by a real limitation of coordinate denoising (Sec. 3; App. B.3).
-
The empirical coverage is broad and includes informative case studies. The paper evaluates on ATLAS ensembles, MDGen tetrapeptides, CATH2-OOD20 kinetics, ADK transition paths and DD-13M ligand dissociation, spanning ensemble statistics, torsion/TICA/MSM distributions, first-passage kinetics and path-level physical quality. The ADK closed-to-open case study (Fig. 2, Sec. 5.4) and the ligand dissociation examples (Fig. 3) make the behavior concrete rather than purely metric-driven.
-
The analysis and visualization are extensive. The paper goes beyond aggregate metrics: zoomed-in views of individual generated paths (Fig. 2a, Fig. 3 callouts), projections onto TICA and free-energy surfaces (Fig. 2c–d), angle-space coverage and per-path PMF exposure for ADK (Fig. A2, Fig. A5). These analyses make the qualitative behavior of the generated trajectories inspectable, not just summarized by a single number.
Critical weaknesses
-
No cross-host QPD ablation. All QPD results use the same Protenix-initialized spatiotemporal denoiser with BioKinema-style training (App. A, C.1). Comparisons to MDGen, STAR-MD, TEMPO and ProTDyn are method-level, not same-host with/without QPD. The paper supports "QPD helps this host", not "QPD is a general training signal", despite framing it as architecture-agnostic.
-
No scale-matching analysis. The same four-increment window spans 4 ps (DD-13M) to 40 ns (CATH2). No ablation varies frame spacing or window length, and no lag-stratified order gap is reported outside the tetrapeptide 10/20 ns lags. Since protein MD order is multi-scale, this is central to the claim.
-
Order vs. static similarity is not decomposed. Hurwitz negatives keep the endpoint but change intermediate poses (App. B.1), and includes per-frame quaternions, so a model could separate positives from negatives by matching static intermediate poses rather than rotation-composition order. The order gap (Table 3b) and frame shuffling (Table A7) alter both static arrangement and order, so they do not isolate the two. A feature-level decomposition of , or a control with identical static poses but different order, would help.
-
No loss-family comparison. The advantage over timestamp/ordering or frame-difference losses is argued (Sec. 3, App. B.1) but not tested. There is no same-host arm with a timestamp regression/ranking loss, a finite-difference loss, or a positive-only regression variant.
-
Window length = 4 is unablated. App. C.1 gives "up to four increments" without justification or a 2/3/4/8 comparison, and it is unclear how 4 was selected.
Questions for authors
- Can the authors add QPD to a differently factorized host (better to be an ensemble generation model, such as AlphaFold or BioEMU, which did not learn order explicitly) under the same budget, and report with/without QPD?
- Can the authors vary frame resolution and window length (2/4/8/16 increments), and report order gap and MFPT correlation by lag?
- Can the authors decompose D_pos and D_neg into static-pose and rotation-composition contributions, or report a feature-level control with identical static pose sets and different order?
- Can the authors add same-host arms with a timestamp/ordering loss and a frame-difference loss, and report order gap, MFPT, TICA/MSM JSD, and static W1 side by side?
- Was the four-increment window selected on validation data? What happens with 2, 3, 8?
4 comments
W3/Q3. Order and static similarity are not decomposed. Can the authors decompose and , or report a control with identical static pose sets and different order?
We first clarify that contains no per-frame quaternion. As defined in Section 4.3, its entries are the products and commutators of contiguous sub-windows with (Equation 4), all built from relative rotations between frames. We have added this sentence to Section 4.3 of the updated manuscript.
To address your comment, we ran the control you describe and the decomposition together. For every five-frame window of the validation tetrapeptides IMCP, YVTL, and GQGV (2,231 windows), we keep the two end frames and reverse the three interior frames. The reversed window has the same end frames, the same net rotation, and the same set of static poses as the reference, in a different order. We score the two models of Table 3b with the reversed window as the negative, and split each distance into its product and commutator entries (Table R15).
Table R15. Same static pose set, different order (mean over 2,231 windows). The product and commutator parts sum to the total.
| Model | Entries | ↓ | ↑ | ↑ |
|---|---|---|---|---|
| QPD (full) | All | 0.0228 | 0.0484 | 0.0255 |
| Products | 0.0160 | 0.0355 | 0.0195 | |
| Commutators | 0.0068 | 0.0128 | 0.0060 | |
| w/o QPD loss | All | 0.0300 | 0.0392 | 0.0091 |
| Products | 0.0216 | 0.0286 | 0.0070 | |
| Commutators | 0.0084 | 0.0106 | 0.0021 |
With the pose set fixed, the mean separation is 0.0255 with QPD against 0.0091 without it, and it is positive on 81.6% against 62.0% of windows. Both products and commutators contribute, with 0.0126 and 0.0038 of the difference. The control shows that the QPD model is sensitive to order when the pose set is fixed. We have incorporated this into Section 5.3 and Appendix B.2 (Table A2) of the updated manuscript.
W4/Q4. Can the authors add same-host arms with a timestamp/ordering loss and a frame-difference loss, and a positive-only variant?
To address your comment, we trained a temporal ranking loss, a frame-difference loss, a framewise orientation loss, and an increments-only loss on the same host, with the loss weight, warm-up, and budget of QPD. The positive-only variant is the "w/o Hurwitz negatives" row of Table 3b. We present them side by side in Table R16.
Table R16. Loss families on the same host (100 test tetrapeptides, mean over three replicates).
| Training objective | 10 ns err. ↓ | 20 ns err. ↓ | Order gap ↑ | Pair (Å) ↓ | TICA-0,1 JSD ↓ | MSM JSD ↓ |
|---|---|---|---|---|---|---|
| w/o QPD loss | 0.166 | 0.154 | 0.002 | 0.456 | 0.312 | 0.233 |
| Temporal ranking | 0.165 | 0.153 | 0.004 | 0.466 | 0.302 | 0.228 |
| Framewise orientation | 0.165 | 0.152 | 0.003 | 0.467 | 0.305 | 0.229 |
| Frame difference | 0.164 | 0.150 | 0.005 | 0.470 | 0.312 | 0.233 |
| Increments only | 0.162 | 0.152 | 0.004 | 0.464 | 0.300 | 0.226 |
| QPD w/o Hurwitz negatives (positive only) | 0.162 | 0.148 | 0.004 | 0.468 | 0.303 | 0.228 |
| QPD (full) | 0.158 | 0.143 | 0.012 | 0.470 | 0.296 | 0.224 |
Every auxiliary loss without the Hurwitz negatives has an order gap of 0.003 to 0.005. Full QPD reaches 0.012, with the lowest angular errors and the lowest TICA and MSM JSD. On CATH2-OOD20, the MFPT correlation is 0.766 for framewise orientation, 0.775 for frame difference, 0.773 for increments only, and 0.784 for the positive-only variant, against 0.805 for full QPD and 0.763 without the QPD loss. All auxiliary losses have a pair about 0.01 Å above the control. We have incorporated this into Section 5.3 (Table 4a) and Appendix D.3 (Table A15) of the updated manuscript.
W5/Q5. Was the four-increment window selected on validation data? What happens with 2, 3, 8?
We set the four-increment window before training and used it on every benchmark. Windows of 2, 3, and 8 increments are in Table R13 of our reply to W2/Q2: three, four, and eight increments give the same order gap within 0.002, and four has the lowest 20 ns error. We have incorporated this into Section 5.3 (Table 4b) and Appendix D.3 (Table A16) of the updated manuscript.
Thanks to the authors' detailed response, which has addressed some of my concerns, I keep my positive rating.
Thank you for the follow-up. We’re glad our response addressed some of your concerns. Please let us know if there’s anything else you’d like us to address.
Dear Reviewer oG4W, thank you for your time and for the careful questions. In the updated manuscript, changes are highlighted in blue.
We address your comments one by one.
W1/Q1. Can the authors add QPD to a differently factorized host, preferably an ensemble generator such as AlphaFold or BioEmu?
To address your comment, we added QPD to MDGen. QPD is defined on consecutive frames of one trajectory. AlphaFold and BioEmu draw independent structures with no time index, so they provide no window on which increments, products, or a Hurwitz move can be formed. MDGen is a differently factorized host on which the loss is defined: it generates SE(3)-invariant tokens with stochastic interpolants instead of denoising all-atom coordinates. We trained it on the tetrapeptide split with and without the QPD loss (Table R12).
Table R12. QPD on two hosts (100 test peptides; MDGen rows: mean over three replicates).
On MDGen the loss lowers the 10 and 20 ns angular errors from 0.173 to 0.161 and from 0.161 to 0.149, raises the order gap from 0.004 to 0.007, and improves pair W1 and TICA JSD. For ensemble generation, Table 1 scores our host under the AlphaFlow ensemble protocol on ATLAS, where QPD lowers RMWD from 2.01 to 1.93 Å and joint-PCA W2 from 1.65 to 1.56 Å. We have incorporated this into Section 5.2 and Appendix D.2 (Table A12) of the updated manuscript.
W2/Q2. Can the authors vary frame resolution and window length, and report order gap and MFPT correlation by lag?
(a) Window length and frame spacing.
To address your comment, we retrained the tetrapeptide model with other window lengths and frame spacings (Table R13).
Table R13. Window length and frame spacing on tetrapeptides (100 test peptides, mean over three replicates). Hurwitz negatives are built on windows of three or more increments, so the two-increment arm has none.
Two increments, where no Hurwitz negative exists, fall to the gap of QPD without negatives (0.004, Table 3b). At 20 and 40 ps spacing the gap is 0.008 and 0.006, and the window span grows to 80 and 160 ps; 160 ps is the span of 16 increments at 10 ps. The two error columns are stratified by lag (10 and 20 ns).
Across benchmarks, the share of candidate windows on which the Hurwitz negative is separable grows with the physical span of the window: 2.7% at 4 ps on DD-13M, 30.2% at 40 ps on tetrapeptides, and 52.4% at 40 ns on CATH2 (Appendix C.1). The effect of QPD follows this share, from no change on DD-13M to the gains of Table 3b on tetrapeptides and CATH2.
(b) By lag.
We recomputed the CATH2-OOD20 kinetics of one pair of models at 10, 100, and 200 ns lag (Table R14).
Table R14. CATH2-OOD20 kinetics by Markov-model lag, on state pairs with a finite MFPT under both models. Entries are QPD / without the QPD loss, then the difference with its 95% paired bootstrap interval over domains.
For this pair the difference in correlation is positive at the 100 ns lag of the benchmark protocol, and the intervals at all three lags include zero. The three-seed gain of Table 3 (0.805 ± 0.010 against 0.763 ± 0.016) is at the 100 ns lag. The order gap on CATH2 is 0.009 at 10 ns and 0.013 at 20 ns, against 0.003 and 0.004 for the control (Table A13). We have incorporated these into Section 5.3 (Table 4b) and Appendix D.3 (Tables A16 and A17) of the updated manuscript, and Section 6 states the lag at which the gain is measured.